Numerous emerging therapies for focused treatments on psoriasis and psoriatic arthritis (PsA) are authorized. Tumor necrosis factor (TNF) inhibitors, interleukin (IL)-12/23 inhibitors, IL-17 inhibitors, selective co-stimulation modulators, phosphodiesterase 4 inhibitors, and Janus kinase inhibitors are among the biologics that are added to the treatment regime for psoriasis and PsA in recent years. Join an exclusive session with "Emerging Treatments for Psoriasis” with eminent dermatologist, Dr. Col.
Biju Vasudevan , on 1 st September 2023, 6:00 PM IST onwards. Moderator: Dr. Rashmi Mahajan Stay tuned Suggested readings USFDA Approves Treatment for Plaque Psoriasis in Adults Secukinumab for Plaque Psoriasis: Evidence Based on the Real-world Clinical Scenario ##Disclaimer## The content provided on Docplexus is intended for educational purposes only. While we strive to ensure…
